Hint mode is switched on Switch off
For swift navigation between sections

Lakefront Biotherapeutics
LEI 549300QKJ78IY0IOV655

PDF download

Choose all Reset all
Download Cancel
Organization name
Lakefront Biotherapeutics NV
Country name
Belgium
Country of registration
Belgium
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Lakefront Biotherapeutics NV is a Belgiumbased company. The Company develops medicines for patients with serious diseases in areas of unmet medical need and uses dealmaking capabilities and capital to identify, acquire, and advance opportunities that create value for patients and shareholders. Its pipeline includes clinicalstage immunology and oncology programs, such as autoimmune disease candidates and selected oncology assets, primarily advanced through partnerships and targeted development rather than inhouse cell therapy platforms. It builds a portfolio of clinicalstage therapies intended to support existing treatment approaches and operates across oncology and immunology and inflammation programs supported by clinical proof of concept in emerging therapeutic areas.

Awards

Documentation

IFRS/US GAAP reports

2025
IV q eng
2024
IV q eng
2023
IV q eng
2022
IV q eng
2021
IV q eng
2020
IV q eng
2019
IV q eng
2018
IV q eng
2017
IV q eng
Show all Hide
Authorization required
You need to request access

Affiliates

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    549300QKJ78IY0IOV655
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001421876
  • Numero d’entreprise / Ondernemingsnummer
    0466460429
Registration is required to get access.